Ranbaxy Laboratories consolidated loss widens in Oct-Dec quarter
Source: IRIS | 28 Jan, 2015, 05.47PM
|
|
|
|
Rating: NAN / 5 stars. |
Comments | Post Comment |
|
Ranbaxy Laboratories said its net consolidated loss for the quarter ended December 2014 has widened to Rs 10,297.27. It reported a net loss of Rs 1,589.44 million in the same quarter last year. Net sales for the quarter declined 9.51% to Rs 26,188.46 million, compared with Rs 28,939.92 million for the prior year period. Earnings per share stood negative at Rs 24.26 compared with negative Rs 3.76 in the same quarter last year.
Quarterly Results - consolidated (Rs in mn) | As at | Dec - 14 | Dec - 13 | %Change | Net Sales | 26,188.46 | 28,939.92 | (9.51) | Net Profit | (10,297.27) | (1,589.44) | - | Basic EPS | (24.26) | (3.76) | - |
|
|
|
|
|
|
|
|
|
|
|
|